Analyst Ratings for Brickell Biotech Inc. (BBI) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/8/2022 | William Blair » Updated 5/4/2022 |
Tim Lugo | New Coverage | Outperform (N/A) |
N/A (N/A) |
0.20 (2.35) |
1075% | Details |
1/18/2022 | H.C. Wainwright | Raghuram Selvaraju | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.21 (2.35) |
1019.05% | Details |
Like BBI Ratings? Also take a look at FRTX
BBI Ratings News
- Lake Street Capital Markets Downgrades Brickell Biotech Inc. (BBI) to Hold
- Brickell Biotech Inc. (BBI) PT Lowered to $1 at Oppenheimer, But Analyst Reiterates Buy Rating on BBI-02 Potential
- William Blair Reiterates Outperform Rating on Brickell Biotech (BBI) on SB Sale, "Valuation Holds Strong Risk/Reward Profile"
- See More